Samuel N. Hazen

Samuel N. Hazen (chief executive) discloses dealings in HCA Healthcare, Inc. to SEC (Form 4). We count 43 filings; the first trade dates from 25 February 2016 and the latest from 10 February 2026.

Sales make up the whole of the open-market record (5 sales, €25.0M). Outside the open market, there are 17 share grants and 15 option exercises. Since January 2026: no purchases and 1 sale on the market.

The latest filing, published on 12 February 2026, reports a share grant in HCA Healthcare, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.